United Kingdom

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

8:59pm GMT
Change (% chg)

$0.05 (+1.59%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization,... (more)


Beta: 1.14
Market Cap(Mil.): $130.63
Shares Outstanding(Mil.): 34.84
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Harvard Bioscience reports Q3 loss $0.01/shr

* Harvard Bioscience reports third quarter 2017 financial results

26 Oct 2017

BRIEF-Harvard Bioscience appoints Katherine Eade, Thomas Loewald to board

* Harvard Bioscience appoints Katherine Eade and Thomas Loewald to the board of directors Source text for Eikon: Further company coverage:

25 Oct 2017

BRIEF-Harvard Bioscience says First Light Asset Management reports 10.3 pct passive stake in Harvard - SEC Filing

* First Light Asset Management Reports 10.3 Pct Passive Stake In Harvard Bioscience Inc As of june 30 - SEC Filing Source text for Eikon: Further company coverage:

07 Jul 2017

Earnings vs. Estimates